Literature DB >> 17632005

Effector proteins translocated by Legionella pneumophila: strength in numbers.

Shira Ninio1, Craig R Roy.   

Abstract

The Gram-negative bacterium Legionella pneumophila is a parasite of eukaryotic cells. It has evolved to survive and replicate in a wide range of protozoan hosts and can also infect human alveolar macrophages as an opportunistic pathogen. Crucially for the infection process, L. pneumophila uses a type IV secretion system called Dot/Icm to translocate bacterial proteins into host cells. In recent years a large number of Dot/Icm-translocated proteins have been identified. The study of these proteins, referred to as effectors, is providing valuable insight into the mechanism by which an intracellular pathogen can manipulate eukaryotic cellular processes to traffic and replicate in host cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632005     DOI: 10.1016/j.tim.2007.06.006

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  109 in total

1.  The overlapping host responses to bacterial cyclic dinucleotides.

Authors:  Ali A Abdul-Sater; Andrzej Grajkowski; Hediye Erdjument-Bromage; Courtney Plumlee; Assaf Levi; Michael T Schreiber; Carolyn Lee; Howard Shuman; Serge L Beaucage; Christian Schindler
Journal:  Microbes Infect       Date:  2011-09-10       Impact factor: 2.700

2.  E3 ubiquitin ligase activity and targeting of BAT3 by multiple Legionella pneumophila translocated substrates.

Authors:  Alexander W Ensminger; Ralph R Isberg
Journal:  Infect Immun       Date:  2010-06-14       Impact factor: 3.441

3.  The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates.

Authors:  Daniel E Voth; Paul A Beare; Dale Howe; Uma M Sharma; Georgios Samoilis; Diane C Cockrell; Anders Omsland; Robert A Heinzen
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

4.  Inhibition of pathogen-induced apoptosis by a Coxiella burnetii type IV effector protein.

Authors:  Anja Lührmann; Catarina V Nogueira; Kimberly L Carey; Craig R Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-13       Impact factor: 11.205

5.  Coxiella burnetii type IVB secretion system region I genes are expressed early during the infection of host cells.

Authors:  John K Morgan; Brandon E Luedtke; Herbert A Thompson; Edward I Shaw
Journal:  FEMS Microbiol Lett       Date:  2010-08-18       Impact factor: 2.742

6.  Life Stage-specific Proteomes of Legionella pneumophila Reveal a Highly Differential Abundance of Virulence-associated Dot/Icm effectors.

Authors:  Philipp Aurass; Thomas Gerlach; Dörte Becher; Birgit Voigt; Susanne Karste; Jörg Bernhardt; Katharina Riedel; Michael Hecker; Antje Flieger
Journal:  Mol Cell Proteomics       Date:  2015-11-06       Impact factor: 5.911

7.  Alveolar macrophages and neutrophils are the primary reservoirs for Legionella pneumophila and mediate cytosolic surveillance of type IV secretion.

Authors:  Alan M Copenhaver; Cierra N Casson; Hieu T Nguyen; Thomas C Fung; Matthew M Duda; Craig R Roy; Sunny Shin
Journal:  Infect Immun       Date:  2014-08-04       Impact factor: 3.441

Review 8.  Coxiella type IV secretion and cellular microbiology.

Authors:  Daniel E Voth; Robert A Heinzen
Journal:  Curr Opin Microbiol       Date:  2009-01-12       Impact factor: 7.934

9.  Systematic Identification of Host Cell Regulators of Legionella pneumophila Pathogenesis Using a Genome-wide CRISPR Screen.

Authors:  Edwin E Jeng; Varun Bhadkamkar; Nnejiuwa U Ibe; Haley Gause; Lihua Jiang; Joanne Chan; Ruiqi Jian; David Jimenez-Morales; Erica Stevenson; Nevan J Krogan; Danielle L Swaney; Michael P Snyder; Shaeri Mukherjee; Michael C Bassik
Journal:  Cell Host Microbe       Date:  2019-09-17       Impact factor: 21.023

Review 10.  Anaplasma phagocytophilum and Ehrlichia chaffeensis type IV secretion and Ank proteins.

Authors:  Yasuko Rikihisa; Mingqun Lin
Journal:  Curr Opin Microbiol       Date:  2010-01-05       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.